$NVAX NVAX - Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccina…

SEC 13D/G

NVAX - Novavax, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified

$7.86▲ 10.08%Aug 7, 2026 · ThinkSabio Blog

$NVAX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #NVAX Novavax, Inc. : $7.86 Sector: Healthcare | YTD: 🔼+ 10.08%…